Rationale: Epithelial-myoepithelial carcinoma (EMC) is regarded as a rare low-grade malignant tumor of the salivary gland, accounting for 0.4% to 1% of all salivary gland tumors. However, epithelial-myoepithelial carcinoma with high-grade transformation (EMC with HGT) is extremely rare, therefore it is easily to be inappropriately diagnosed and treated. Herein, we report an unusual case of EMC with HGT involving the parotid gland and discuss the clinical features and histological characteristic of EMC with HGT, in order to remind the doctors to take appropriate diagnosis and treatment.
Introduction
Epithelial-myoepithelial carcinoma (EMC) is a rare malignant neoplasm of the salivary gland, accounting for 0.4% to 1% of all salivary gland tumors. [1] Typically, the EMC is described as a firm tumor, which is hard to invade to the adjacent tissues.
Although it has a high rate of recurrence ranging from 35% to 40%, the mortality is low. [2] Therefore, it is considered as a lowgrade tumor. Histologically, the EMC generally presents a typical biphasic pattern composing of 2 cell types with variable proportions. The morphology shows the clear myoepithelial cells surround the epithelium-lined ducts, which resemble intercalated ducts in the inner layer. [3] However, several new morphologic subtypes of EMC, which includes double clear EMC, oncocytic EMC, sebaceous EMC, apocrine EMC, EMC ex pleomorphic adenoma as well as EMC with high-grade transformation (HGT) have been recognized recently. [4] HGT is defined as a histological progression of low-grade tumor to high-grade morphology, where the original histological characteristics are lost. [5] The concept of HGT was also known as dedifferentiation previously [6] and was first proposed by Dahlin and Beabout in 1971. The HGT components commonly reported to be undifferentiated carcinoma, poorly differentiated adenocarcinoma or high-grade myoepithelial carcinoma, [5] so the conventional and high-grade transformation components are distinguishable. Recently, this phenomenon of EMC has been define as the concept of HGT, but EMC with HGT is extremely rare. [3] Due to few cases were reported, the clinicopathologic features and treatment of this neoplasm are not yet clear.
In this report, we present an interesting case of EMC with HGT located in the left parotid gland. To our knowledge, there are only 21 EMC with HGT cases reported in the literature to date. Patient provided written informed consent.
Case report
A 77-year-old female sought for treatment in our hospital due to pain mass in the left parotid gland. The lesion was symptomatic and had been present about 6 months with a recent rapid increase in size. The patient reported no prior surgeries.
Upon examination, there was a 3.5 Â 3.0 Â 1.5 cm medium texture, unclear boundary, immobile, and pain mass, but the facial nerve function was intact. There was no palpable lymphadenopathy. The remaining oral cavity and head and neck examinations were normality.
A large mass sized 35 Â 30 Â 15 mm in the left parotid gland was identified on MRI (Fat suppressed T2-weighted images showed mild hyperintensity, T1-weighted images showed hyperintensity). The mass was heterogeneous and had an unclear margin, so MRI suggested the mass could be a malignant tumor.
At surgery, we remove the tumor to the biopsy, and then the lesion was considered as a malignant neoplasm. The tumor was not invaded to adjacent tissues, so the patient subsequently underwent extensive resection of the tumor with a safety margin of 1 cm under general anesthesia. Then the tumor was sent for histopathological and immunohistochemistry analysis to confirm the histogenetic origin of the lesion. There were 2 different components including typical EMC and high-grade carcinoma in the lesion. The EMC component includes the inner layer of duct consisted of cuboidal epithelial cells and the outer layer consisted of clear myoepithelial cells. They present various tumor cells, which arrange in trabecular, tubular, or islands. The high-grade transformation component was composing of intensive spindle cells with increased nuclear pleomorphism, mitotic activity, prominent nucleolus and acidophilic cytoplasm. The large amount of spindle cells arranged in fascicular clusters (Fig. 1) . Immunohistochemical examination indicated that the EMC component was diffusely positive to CK. The tumor cells of the EMC were only positive for CD117 in the duct, and the outer myoepithelial cells were positive for P63, Calponin and S-100 (Fig. 2) . However, the high-grade transformation component was all negative for these biomarkers of the typical EMC. The final pathologic diagnosis was the EMC with HGT.
Adjuvant radiotherapy was suggested, but the patient refused the proposition because of her age. Fortunately, no complications were observed during recovery. The patient was uneventful after surgery and no recurrence or metastasis has been observed after follow-up of 4 years.
Discussion
The EMC with HGT is exceedingly rare. HGT may be considered as a slow process with increasing genomic heterogeneity or as a result of an abrupt transition event. So far, 2 forms of the EMC with HGT have been found. The one form was described as EMC with myoepithelial anaplasia or myoepithelial carcinoma arising in EMC, which was defined as severe nuclear atypia and pleomorphism that occurs gradually in the myoepithelial component. [7] [8] [9] The nuclear atypia usually is great than 20% in myoepithelial cells. [10] It means a gradual transition of the myoepithelial component of EMC into a more aggressive carcinoma. In the other form, the ductal component can transform into a high-grade carcinoma but the transition is abrupt and rarely. In addition, there is a large amount of nuclear fission and necrosis in the conversion component. In the present case, there were large areas of typical biphasic EMC but the high-grade transformation component was made of intensive spindle cells with increased nuclear pleomorphism, mitotic activity and prominent nucleolus. Moreover, this high-grade component, being tightness adjacent to those low-grade areas, showed negativity for p63, S-100 and calponin. So the authors consider this case is more accord with the form that the EMC abruptly transform the pleomorphic sarcoma. In order to being fully understand the clinicopathological features, treatment modality and prognosis of EMC with HGT, so a literature search was performed. A summary of all 22 cases including our case are presented in Table 1 . Overall, we found only 21 cases of the EMC with HGT has been reported. The age of patients' ranged from 46 to 103 years and the median age of diagnosis was 72 years. The male to female ratio is 7:11. As we known, the typical EMC has a slight female predominance and has occurred in patients between 8 and 103 years with a mean age of about 60 years, [4] so I speculated the patients with EMC containing a highgrade transformation component have been older than typical EMC patients. The most frequent site was the parotid gland, followed by the submandibular gland and palate. The lymph node and distant metastases were respectively reached up to 40% and 20%. Only one patient had confirmed mortality. The current patient alive 4 years with no recurrence after surgery. However, the EMC is generally regarded as a low-grade malignancy, the local recurrence rate is estimated to be 30%, and the distant metastases are extremely rare in only 4.5%, [1] so the data has been shown to be more aggressive than typical EMC with a high propensity for cervical lymph node and distant metastases. Though the reported cases are limited and follow-up is insufficiency and short, the poor prognosis suggest the patients of EMC with HGT should be necessary with more radical treatment than typical EMC, including wider excision, neck dissection and even adjuvant radiation therapy. [4] In conclusion, the EMC with HGT is extremely rare and the authors described a rare case of EMC with HGT arising in the parotid gland. According to the analysis, it is more aggressive and worse prognosis, so it is significant to accurately diagnose the EMC with HGT to avoid inappropriate treatment. More studies are needed in order to deeply understand the clinical and histopathologic features of the EMC with HGT. www.md-journal.com Table 1 Clinicopathologic summary of 22 cases of EMC with HGT.
Age/sex Location Size, cm HGT component(s)
HGT component staining
Follow-up
Simpson et al [11] Fonseca and Soares [10] Alos et al [12] Manuel et al [13] Seethala et al [7] Kusafuka et al [14] Niederhagen [15] Sarode [16] Roy et al [17] Yang and Chen [4] Kainuma et al [18] Baker et al [2] Suzuki et al [8] 103 [19] 46/female 
